A Phase II Study of Gemcitabine and Erlotinib As Adjuvant Therapy In Patients With Resected Pancreatic Cancer
Clinical trial NCT00336700 · TERMINATED
Trial details
- NCT number
- NCT00336700
- Sponsor
- Herbert J. Zeh, III MD, FACS
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-06-01
- Primary completion
- 2011-10-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.